Skip to main content

Neurology and Therapy

Ausgabe 2/2020

Inhalt (30 Artikel)

Open Access Commentary

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Antonio Bertolotto, Serena Martire, Luca Mirabile, Marco Capobianco, Marco De Gobbi, Daniela Cilloni

Open Access Review

A Review of the Recent Findings in Minimally Invasive Treatment Options for the Management of Occipital Neuralgia

Ivan Urits, Ruben H. Schwartz, Parth Patel, Justin Zeien, Denton Connor, Jamal Hasoon, Amnon A. Berger, Hisham Kassem, Laxmaiah Manchikanti, Alan D. Kaye, Omar Viswanath

Open Access Review

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region

Raed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, Jaber Alkhabouri, Taoufik Alsaadi, Abdullah Alsalti, Amir Boshra, Beatriz Canibano, Samar Farouk Ahmed, Ahmed Shatila

Open Access Review

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis

María José Sá, Ricardo Soares dos Reis, Ayse Altintas, Elisabeth Gulowsen Celius, Claudia Chien, Giancarlo Comi, Francesc Graus, Jan Hillert, Jeremy Hobart, Gulfaraz Khan, Najib Kissani, Dawn Langdon, Maria Isabel Leite, Darin T. Okuda, Jacqueline Palace, Regina María Papais-Alvarenga, Inês Mendes-Pinto, Fu-Dong Shi

Open Access Review

A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis

Ivan Urits, Daniel Swanson, Michael C. Swett, Anjana Patel, Kevin Berardino, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Alan D. Kaye, Omar Viswanath

Open Access Review

Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis

Maria Pia Sormani, Robert Wolff, Shona Lang, Steven Duffy, Robert Hyde, Elizabeth Kinter, Craig Wakeford, Gavin Giovannoni, Jos Kleijnen

Open Access Review

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis

Gavin Giovannoni, Shona Lang, Robert Wolff, Steven Duffy, Robert Hyde, Elizabeth Kinter, Craig Wakeford, Maria Pia Sormani, Jos Kleijnen

Open Access Review

Acupuncture and Its Role in the Treatment of Migraine Headaches

Ivan Urits, Megha Patel, Mary Elizabeth Putz, Nikolas R. Monteferrante, Diep Nguyen, Daniel An, Elyse M. Cornett, Jamal Hasoon, Alan D. Kaye, Omar Viswanath

Open Access Review

A Narrative Review of the Role of Transthyretin in Health and Disease

Marcia Almeida Liz, Teresa Coelho, Vittorio Bellotti, Maria Isabel Fernandez-Arias, Pablo Mallaina, Laura Obici

Open Access Review

An Evidence-Based Review of Galcanezumab for the Treatment of Migraine

Ivan Urits, Melis Yilmaz, Karina Charipova, Kyle Gress, Ehab Bahrum, Michael Swett, Amnon A. Berger, Hisham Kassem, Anh L. Ngo, Elyse M. Cornett, Alan D. Kaye, Omar Viswanath

Open Access Review

CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review

Nirmal Chandra Barman, Niuz Morshed Khan, Maidul Islam, Zulkar Nain, Rajib Kanti Roy, Anwarul Haque, Shital Kumar Barman

Open Access Original Research

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies

Antonio Bertolotto, Rafael Arroyo, Elisabeth G. Celius, Giancarlo Comi, Eva Kubala Havrdova, William David Honeycutt, Samuel F. Hunter, Guillermo Izquierdo, Barbara Kornek, Tamara Miller, Dimos D. Mitsikostas, Barry A. Singer, Tjalf Ziemssen, Luke Chung, Nadia Daizadeh, Salman Afsar, Lobat Hashemi, Peter Senior

Open Access Original Research

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

Timothy Smith, John H. Krege, Suchitrita S. Rathmann, Sherie A. Dowsett, Ann Hake, Emel S. M. Nery, Brandy R. Matthews, Erin G. Doty

Open Access Original Research

The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data

Sheila R. Reddy, Eunice Chang, Marian H. Tarbox, Michael S. Broder, Ryan S. Tieu, Spencer Guthrie, Montserrat Vera-Llonch, Michael R. Pollock

Open Access Original Research

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM

Mitzi J. Williams, Lilyana Amezcua, Annette Okai, Darin T. Okuda, Stanley Cohan, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin, Cynthia C. Jones

Open Access Original Research

Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM

Angel Chinea, Lilyana Amezcua, Wendy Vargas, Annette Okai, Mitzi J. Williams, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin, Cynthia C. Jones

Open Access Original Research

Impact of Formulary Restrictions on Antiepileptic Drug Dispensation Outcomes

Darshan Mehta, Matthew Davis, Andrew J. Epstein, Andrew Lee

Open Access Original Research

Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials

Amir A. Tahami Monfared, Mitesh Desai, Robert Hughes, Stefano Lucherini, Yunni Yi, Richard Perry

Open Access Original Research

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries

Michael J. Doane, Shaloo Gupta, Juanzhi Fang, Annik K. Laflamme, Pamela Vo

Open Access Original Research

Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey)

Siriporn Wongsiriroj, Elisabetta Grillo, Sabrina Levi, Ronald Zielman, Elia Lahouiri, Marco Marchina, Marco Pedrazzoli, Matias Ferraris

Open Access Original Research

Reliability and Validity of the Persian Version of the Mini-Balance Evaluation Systems Test in Patients with Stroke

Soofia Naghdi, Noureddin Nakhostin Ansari, Bijan Forogh, Maedeh Khalifeloo, Roshanak Honarpisheh, Amin Nakhostin-Ansari

Open Access Original Research

Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy

Dylan Trundell, Stephanie Le Scouiller, Ksenija Gorni, Timothy Seabrook, Carole Vuillerot

Open Access Original Research

Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses

Darshan Mehta, Matthew Davis, Andrew J. Epstein, Brian Wensel, Todd Grinnell, G. Rhys Williams

Open Access Brief Report

Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment

Christine Lebrun-Frenay, Ilona Berestjuk, Mikael Cohen, Sophie Tartare-Deckert

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.